DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $12,810,000 | -52.4% | 635,400 | -11.8% | 0.06% | -53.7% |
| Q2 2021 | $26,885,000 | +73.4% | 720,400 | +18.8% | 0.12% | +68.1% |
| Q1 2021 | $15,507,000 | -70.3% | 606,439 | -74.4% | 0.07% | -71.7% |
| Q4 2020 | $52,128,000 | +164.2% | 2,366,225 | +120.3% | 0.25% | +58.8% |
| Q1 2020 | $19,727,000 | -28.9% | 1,073,881 | -14.8% | 0.16% | +9.6% |
| Q4 2019 | $27,763,000 | +40.4% | 1,260,216 | -6.7% | 0.15% | +62.2% |
| Q1 2019 | $19,778,000 | +141171.4% | 1,350,000 | +224900.0% | 0.09% | – |
| Q1 2015 | $14,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,813,392 | $67,676,000 | 17.58% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $114,954,000 | 7.53% |
| RTW INVESTMENTS, LP | 7,521,859 | $280,716,000 | 4.24% |
| DAFNA Capital Management LLC | 510,756 | $19,061,000 | 3.99% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 229,892 | $8,580,000 | 3.83% |
| Parkman Healthcare Partners LLC | 304,686 | $11,371,000 | 2.49% |
| Evolutionary Tree Capital Management, LLC | 141,324 | $5,274,000 | 2.43% |
| Eagle Health Investments LP | 161,125 | $6,013,000 | 2.06% |
| Lombard Odier Asset Management (Switzerland) SA | 636,011 | $23,736,000 | 1.20% |
| Woodline Partners LP | 1,000,325 | $37,332,000 | 0.70% |